Industry News
Stem cell signal linked with cancer growth
Feb 04, 2014
Researchers at the University of California, San Diego School of Medicine have identified a protein critical to hematopoietic stem cell function and blood formation. The finding has potential as a new target for treating leukemia because cancer stem cells rely upon the same protein to regulate and sustain their growth.Hematopoietic stem cells give rise to all other blood cells. Read More
Success reported in targeted therapy for common form of lung cancer
Feb 04, 2014
The most common genetic subtype of lung cancer, which has long defied treatment with targeted therapies, has had its growth halted by a combination of two already-in-use drugs in laboratory and animal studies, setting the stage for clinical trials of the drugs in patients, researchers at Dana-Farber Cancer Institute and other scientists report in a new study. Read More
Protein serves as a natural boost for immune system fight against tumors
Feb 04, 2014
Substances called adjuvants that enhance the body's immune response are critical to getting the most out of vaccines. These boosters stimulate the regular production of antibodies -- caused by foreign substances in the body -- toxins, bacteria, foreign blood cells, and the cells of transplanted organs. Read More
Genetically diverse cancer cells key to brain tumor resistance
Feb 04, 2014
For a cancer cell, it pays to have a group of eccentric friends. Like X-Men characters, a group of cancer cells with diverse physical traits is safer, because it takes different strategies to kill each member.The more diverse the group, the better the chances are for individual cells to survive and join forces as a cohesive tumor. Read More
Marker may predict response to ipilimumab in advanced melanoma
Feb 04, 2014
Among patients with advanced melanoma, presence of higher levels of the protein vascular endothelial growth factor (VEGF) in blood was associated with poor response to treatment with the immunotherapy ipilimumab, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research. Read More
Success reported in targeted therapy for common form of lung cancer
Feb 04, 2014
The most common genetic subtype of lung cancer, which has long defied treatment with targeted therapies, has had its growth halted by a combination of two already-in-use drugs in laboratory and animal studies, setting the stage for clinical trials of the drugs in patients, researchers at Dana-Farber Cancer Institute and other scientists report in a new study. Read More
Simple, at-home test will detect most colorectal cancers
Feb 03, 2014
Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine. Read More
Simple, at-home test will detect most colorectal cancers
Feb 03, 2014
Tests that require patients to collect a single stool sample at home and then send it to a lab for analysis will detect about 79 percent of colorectal cancers, according to a new evidence review published in the Annals of Internal Medicine. Read More
HPV vaccine 'does not lead to risky sexual behavior in teens'
Feb 03, 2014
Some parents might worry that the human papillomavirus vaccine could lead to more sex or more unsafe sex in teenagers and young people. However, a new study conducted by the Cincinnati Children's Hospital Medical Center in Ohio and published in the Pediatrics journal finds that these concerns are unwarranted. Read More
Immune system kills spontaneous blood cancer cells every day
Feb 03, 2014
A new study from Australia suggests B cells, a type of white blood cell, undergo spontaneous changes that could lead to cancer if the immune system does not carry out regular checks and kill them before they form tumors.In the journal Nature Medicine, Dr. Read More
Previous Page Next Page